SCIENCE IN THE NEWS DAILY
In Study, Drug Delays Worsening of Breast Cancer, With Fewer Side Effects
from the New York Times (Registration Required)
CHICAGO -- A drug that delivers a powerful poison to tumors without some of the side effects of traditional treatments can delay the worsening of breast cancer and also appears to substantially prolong lives, according to results of a study presented here [the American Society of Clinical Oncology] Saturday.
Besides representing an advance in treating breast cancer, the success in the clinical trial validates an idea that is now being pursued by numerous pharmaceutical companies to treat various types of cancer in a way that delivers drugs to cancerous cells while sparing healthy ones.
"We've envisioned a world where cancer treatment would kill the cancer and not hurt the patient," Dr. Kimberly L. Blackwell, a professor of medicine at the Duke Cancer Institute and the lead investigator in the trial, said in an interview. "And this drug does that."
Connect With Us:
VIDEO: The Promise and Peril of Drones
The automation of tasks at work and at home is just around the corner, including driving cars, piloting planes, delivering packages, and transporting weapons. Unmanned aerial vehicles are rapidly evolving to meet both society’s and the military’s needs in automation and better efficiency.
During her time as one of the first female fighter pilots in the US Navy, Dr. Missy Cummings observed that computers could take off and land a plane more precisely than humans. Because of this breakthrough and her fascination with this growing technology, she began human–drone interaction research.
To view all multimedia content, click "Latest Multimedia."
Receive notification when new content is posted from the entire website, or choose from the customized feeds available.